Skip to main content

Oxford Cannabinoid Technologies "proceeding forward as planned" after review meeting

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) CEO Clarissa Sowemimo-Coker speaks to Proactive after announcing that a Research Ethics Committee (REC) review meeting for its lead programme OCT461201 has now taken place. Sowemimo-Coker says the company is "proceeding forward as planned" and has "hit the ground running" in 2023.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  216.75
-0.39 (-0.18%)
AAPL  269.37
+3.12 (1.17%)
AMD  202.23
-3.79 (-1.84%)
BAC  51.09
+0.09 (0.18%)
GOOG  297.16
+7.18 (2.48%)
META  588.08
-1.07 (-0.18%)
MSFT  470.14
-8.29 (-1.73%)
NVDA  179.16
-1.48 (-0.82%)
ORCL  199.15
-11.54 (-5.48%)
TSLA  397.05
+1.82 (0.46%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.